NRTN
Neurturin
Also known as: NRTN_HUMAN, NTN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99748
- Gene
- NRTN
- Ensembl
- ENSG00000171119
- Chromosome
- 19
- Canonical length
- 197 aa
- Protein class
- Disease related genes, Predicted secreted proteins
- Subcellular location
- Golgi apparatus
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. The encoded preproprotein is proteolytically processed to generate the mature protein. This protein signals through the RET receptor tyrosine kinase and a GPI-linked coreceptor, and promotes survival of neuronal populations. A neurturin mutation has been described in a family with Hirschsprung Disease. [provided by RefSeq, Aug 2016]
Canonical amino-acid sequenceUniProt
197 residues, UniProt reviewed canonical sequence.
>Q99748|NRTN
1 MQRWKAAALA SVLCSSVLSI WMCREGLLLS HRLGPALVPL HRLPRTLDAR IARLAQYRAL
61 LQGAPDAMEL RELTPWAGRP PGPRRRAGPR RRRARARLGA RPCGLRELEV RVSELGLGYA
121 SDETVLFRYC AGACEAAARV YDLGLRRLRQ RRRLRRERVR AQPCCRPTAY EDEVSFLDAH
181 SRYHTVHELS ARECACVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NRTN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 19 nTPM
- pancreas: 13 nTPM
- liver: 11 nTPM
- colon: 7.1 nTPM
- stomach: 7 nTPM
- retina: 6.3 nTPM
Single-cell type
- esophageal apical cells: 137 nCPM
- rod photoreceptor cells: 97 nCPM
- enterocytes: 77 nCPM
- paneth cells: 54 nCPM
- salivary acinar cells: 45 nCPM
- cone photoreceptor cells: 37 nCPM
Immune cell
- plasmacytoid DC: 0.2 nTPM
- T-reg: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- midbrain: 1.3 nTPM
- pons: 1.2 nTPM
- medulla oblongata: 1.1 nTPM
- cerebellum: 1 nTPM
- white matter: 1 nTPM
- cerebral cortex: 0.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.29
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 0.68
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor protein tyrosine kinase signaling pathway
- cell surface receptor signaling pathway via STAT
- glial cell-derived neurotrophic factor receptor signaling pathway
- MAPK cascade
- nerve development
- nervous system development
- neural crest cell migration
- neuron projection development
Molecular functions
- glial cell-derived neurotrophic factor receptor binding
- growth factor activity
- heparan sulfate binding
- receptor tyrosine kinase binding
- signaling receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NRTN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NRTN as an antibody target. Whether an autoantibody or antibody against NRTN could matter depends on whether native NRTN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NRTN is annotated as secreted, so native NRTN circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label NRTN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...